GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Creo Medical Group PLC (LSE:CREO) » Definitions » 12-1 Month Momentum %

Creo Medical Group (LSE:CREO) 12-1 Month Momentum % : 45.04% (As of May. 27, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Creo Medical Group 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-27), Creo Medical Group's 12-1 Month Momentum % is 45.04%.

The industry rank for Creo Medical Group's 12-1 Month Momentum % or its related term are showing as below:

LSE:CREO's 12-1 Month Momentum % is ranked better than
90.13% of 851 companies
in the Medical Devices & Instruments industry
Industry Median: -19.4 vs LSE:CREO: 45.04

Competitive Comparison of Creo Medical Group's 12-1 Month Momentum %

For the Medical Devices subindustry, Creo Medical Group's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Creo Medical Group's 12-1 Month Momentum % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Creo Medical Group's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Creo Medical Group's 12-1 Month Momentum % falls into.



Creo Medical Group  (LSE:CREO) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Creo Medical Group  (LSE:CREO) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Creo Medical Group 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Creo Medical Group's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Creo Medical Group (LSE:CREO) Business Description

Traded in Other Exchanges
N/A
Address
Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy.

Creo Medical Group (LSE:CREO) Headlines

No Headlines